Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 21, 2012 - Issue 10
Submit an article Journal homepage
336
Views
5
CrossRef citations to date
0
Altmetric
Discontinued Drugs Perspective

Discontinued drugs in 2011: cardiovascular drugs

Hong-Ping ZhaoChina Pharmaceutical University, Center for Instrumental Analysis, Key Laboratory of Drug Quality Control & Pharmacovigilance, Ministry of Education, Nanjing, Jiangsu 210009, China+86 25 8327 1180; +86 25-8327 1335; [email protected]
,
Hong-Min JiangChina Pharmaceutical University, Center for Instrumental Analysis, Key Laboratory of Drug Quality Control & Pharmacovigilance, Ministry of Education, Nanjing, Jiangsu 210009, China+86 25 8327 1180; +86 25-8327 1335; [email protected]
&
Bing-Ren XiangChina Pharmaceutical University, Center for Instrumental Analysis, Key Laboratory of Drug Quality Control & Pharmacovigilance, Ministry of Education, Nanjing, Jiangsu 210009, China+86 25 8327 1180; +86 25-8327 1335; [email protected]
Pages 1449-1462 | Published online: 25 Jul 2012

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Hong-ping Zhao, Yan Dai & Bing-ren Xiang. (2016) Discontinued cardiovascular drugs in 2015. Expert Opinion on Investigational Drugs 25:9, pages 1093-1101.
Read now
Brian Raymer & David Ebner. (2015) Small molecule and peptide therapies for chronic heart failure: a patent review (2011 – 2014). Expert Opinion on Therapeutic Patents 25:10, pages 1175-1190.
Read now
Hong-ping Zhao & Bing-ren Xiang. (2015) Discontinued cardiovascular drugs in 2013 and 2014. Expert Opinion on Investigational Drugs 24:8, pages 1083-1092.
Read now
Hong-Ping Zhao, Hong-Min Jiang & Bing-Ren Xiang. (2013) Discontinued drugs in 2012: cardiovascular drugs. Expert Opinion on Investigational Drugs 22:11, pages 1437-1451.
Read now

Articles from other publishers (1)

Tingting Li, Sida Jiang, Bingwei Ni, Qiuji Cui, Qinan Liu & Hongping Zhao. (2019) Discontinued Drugs for the Treatment of Cardiovascular Disease from 2016 to 2018. International Journal of Molecular Sciences 20:18, pages 4513.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.